The Administrator announces the suspension of Bitstamp as a CME CF Constituent Exchange for certain CME CF Cryptocurrency Pricing Products Family indices, from November 25th, 2024.
The indices are listed below.
Rationale
The Administrator monitors Constituent Exchange trading volumes on an ongoing basis against the CME CF Constituent Exchanges Criteria in order to assess each venue's continuing eligibility to remain a Constituent Exchange. The Administrator has concluded that Bitstamp no longer meets the minimum spot trading volume requirements on a consistent basis. Accordingly, Bitstamp will be suspended as a Constituent Exchange for the benchmarks listed above. This suspension is indefinite.
Implementation Date
Bitstamp will be suspended as a Constituent Exchange from the benchmarks listed above at approximately 11:00 London Time, on November 25th, 2024. The suspension process has been overseen by the CME CF Cryptocurrency Pricing Products Oversight Committee.
Questions or queries regarding the suspension should be directed to [email protected].
Any complaints regarding the suspension can be made confidentially by writing to [email protected]
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
Hyperliquid returns ~83 cents of every fee dollar to HYPE holders via buybacks, far more than Coinbase or Robinhood turn into profit. On fully diluted supply it trades near 61x earnings; our modeling assumes growing market share and puts fair value near $106, about 89% above the June 10 price.

Mark Pilipczuk
Announcement of Consultation on Changes to the CME CF Real Time Indices Methodology

CF Benchmarks
Announcement of Consultation on Changes to the CF Spot Rate Methodology Guide

CF Benchmarks
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.